PL1988085T3 - Sposób wytwarzania estru, 3-[5-[4-(cyklopentyloksy)-2-hydroksybenzoilo]-2-[(3-hydroksy-1,2-benzisoksazol-6-ilo)metoksy]fenylo]propionianu oraz związek pośredni dla tego sposobu - Google Patents

Sposób wytwarzania estru, 3-[5-[4-(cyklopentyloksy)-2-hydroksybenzoilo]-2-[(3-hydroksy-1,2-benzisoksazol-6-ilo)metoksy]fenylo]propionianu oraz związek pośredni dla tego sposobu

Info

Publication number
PL1988085T3
PL1988085T3 PL07714479T PL07714479T PL1988085T3 PL 1988085 T3 PL1988085 T3 PL 1988085T3 PL 07714479 T PL07714479 T PL 07714479T PL 07714479 T PL07714479 T PL 07714479T PL 1988085 T3 PL1988085 T3 PL 1988085T3
Authority
PL
Poland
Prior art keywords
bezisoxazol
hydroxybenzoyl
cyclopentyloxy
methoxy
hydroxy
Prior art date
Application number
PL07714479T
Other languages
English (en)
Inventor
Kenji Yonezawa
Tamotsu Takamatsu
Naokatu Aoki
Tomohiro Hashimoto
Masahiro Takebayashi
Yoshiaki Suzuki
Yuji Oonishi
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of PL1988085T3 publication Critical patent/PL1988085T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/303—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by hydrogenation of unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL07714479T 2006-02-21 2007-02-19 Sposób wytwarzania estru, 3-[5-[4-(cyklopentyloksy)-2-hydroksybenzoilo]-2-[(3-hydroksy-1,2-benzisoksazol-6-ilo)metoksy]fenylo]propionianu oraz związek pośredni dla tego sposobu PL1988085T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2006043777 2006-02-21
JP2006121601 2006-04-26
JP2006121582 2006-04-26
EP07714479.8A EP1988085B8 (en) 2006-02-21 2007-02-19 Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process
PCT/JP2007/052953 WO2007097279A1 (ja) 2006-02-21 2007-02-19 ３－｛５－［４－（シクロペンチルオキシ）－２－ヒドロキシベンゾイル］－２－［（３－オキソ－２－置換－２，３－ジヒドロ－１，２－ベンズイソオキサゾール－６－イル）メトキシ］フェニル｝プロピオン酸エステルの製造法およびその中間体

Publications (1)

Publication Number Publication Date
PL1988085T3 true PL1988085T3 (pl) 2015-04-30

Family

ID=38437319

Family Applications (2)

Application Number Title Priority Date Filing Date
PL12007742T PL2562170T3 (pl) 2006-02-21 2007-02-19 Sposób wytwarzania estru kwasu 3-{5-[4-(cyklopentyloksy)- 2-hydroksybenzoilo]-2-[(3-okso-2-podstawionego-2,3-dihydro-1,2-benzizoksazol-6-ilo)metoksy]fenylo}- propionowego i związku pośredniego dla sposobu
PL07714479T PL1988085T3 (pl) 2006-02-21 2007-02-19 Sposób wytwarzania estru, 3-[5-[4-(cyklopentyloksy)-2-hydroksybenzoilo]-2-[(3-hydroksy-1,2-benzisoksazol-6-ilo)metoksy]fenylo]propionianu oraz związek pośredni dla tego sposobu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL12007742T PL2562170T3 (pl) 2006-02-21 2007-02-19 Sposób wytwarzania estru kwasu 3-{5-[4-(cyklopentyloksy)- 2-hydroksybenzoilo]-2-[(3-okso-2-podstawionego-2,3-dihydro-1,2-benzizoksazol-6-ilo)metoksy]fenylo}- propionowego i związku pośredniego dla sposobu

Country Status (20)

Country Link
US (2) US8017789B2 (pl)
EP (2) EP1988085B8 (pl)
JP (1) JP5236456B2 (pl)
KR (1) KR101374592B1 (pl)
CN (1) CN102285931B (pl)
AU (1) AU2007218772B2 (pl)
BR (1) BRPI0707989A2 (pl)
CA (2) CA2643052C (pl)
CY (2) CY1115763T1 (pl)
DK (2) DK2562170T3 (pl)
ES (2) ES2523822T3 (pl)
IL (2) IL193508A (pl)
MX (1) MX2008010787A (pl)
NO (1) NO20083493L (pl)
NZ (2) NZ593062A (pl)
PL (2) PL2562170T3 (pl)
PT (2) PT1988085E (pl)
SG (1) SG179300A1 (pl)
SI (2) SI1988085T1 (pl)
WO (1) WO2007097279A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG188816A1 (en) * 2008-03-27 2013-04-30 Toyama Chemical Co Ltd Use of benzophenone derivative or salt thereof and tnf alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
CA2721920A1 (en) 2008-04-22 2009-10-29 Toyama Chemical Co., Ltd. Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components
CN103183606B (zh) * 2011-12-28 2016-09-14 天津市国际生物医药联合研究院有限公司 一种4,4'-二取代二苯甲酮类化合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2019335C (en) * 1989-06-27 2000-08-01 Mitoshi Konno Phenylalkan (en)oic acids
LU87821A1 (fr) 1990-10-12 1992-05-25 Cird Galderma Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique
SE9501919L (sv) 1995-05-19 1996-07-01 Dimbis Ab Detektering och prediktion av trafikstörningar
CN100378063C (zh) * 1998-11-05 2008-04-02 富山化学工业株式会社 新型化合物及其医药用途
MXPA04004654A (es) * 2001-11-16 2005-05-17 Toyama Chemical Co Ltd Novedosos derivados de benzofenona o sus sales.
CN1506359A (zh) * 2002-12-05 2004-06-23 �й�ҽѧ��ѧԺҩ���о��� 新的香豆素酰胺衍生物及其制法和其药物组合物与用途
MXPA05008307A (es) * 2003-02-07 2005-09-20 Ono Pharmaceutical Co Compuestos de acidos carboxilicos.
ATE500216T1 (de) 2003-06-25 2011-03-15 Je Il Pharmaceutical Co Ltd Tricyclische derivate oder pharmazeutisch unnbedenkliche salze davon, deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten
CN101798291A (zh) 2003-12-29 2010-08-11 塞普拉科公司 苯并[d]异噁唑-3-醇DAAO抑制剂
JP5117381B2 (ja) * 2006-05-26 2013-01-16 富山化学工業株式会社 ３−｛５−［４−（シクロペンチルオキシ）−２−ヒドロキシベンゾイル］−２−［（３−ヒドロキシ−１，２−ベンズイソオキサゾール−６−イル）メトキシ］フェニル｝プロピオン酸の新規な結晶

Also Published As

Publication number Publication date
IL193508A0 (en) 2009-05-04
DK1988085T3 (en) 2014-12-01
NZ593062A (en) 2012-04-27
US20110263866A1 (en) 2011-10-27
CN102285931A (zh) 2011-12-21
IL219282A (en) 2013-10-31
CA2643052C (en) 2014-02-11
SG179300A1 (en) 2012-04-27
PT2562170E (pt) 2014-12-26
EP1988085A4 (en) 2012-05-30
CA2817676A1 (en) 2007-08-30
BRPI0707989A2 (pt) 2011-05-17
DK2562170T3 (en) 2014-11-24
US8153816B2 (en) 2012-04-10
EP2562170A1 (en) 2013-02-27
EP2562170B1 (en) 2014-10-29
EP1988085A1 (en) 2008-11-05
WO2007097279A1 (ja) 2007-08-30
US20090099369A1 (en) 2009-04-16
JP5236456B2 (ja) 2013-07-17
SI1988085T1 (sl) 2015-03-31
KR20080098666A (ko) 2008-11-11
PT1988085E (pt) 2015-02-05
CA2643052A1 (en) 2007-08-30
PL2562170T3 (pl) 2015-03-31
ES2524474T3 (es) 2014-12-09
CY1115763T1 (el) 2017-01-25
MX2008010787A (es) 2008-10-27
IL219282A0 (en) 2012-06-28
CN102285931B (zh) 2014-01-01
CY1115787T1 (el) 2017-01-25
NZ570634A (en) 2011-08-26
US8017789B2 (en) 2011-09-13
AU2007218772B2 (en) 2012-02-23
SI2562170T1 (sl) 2015-03-31
IL193508A (en) 2013-10-31
NO20083493L (no) 2008-08-14
AU2007218772A1 (en) 2007-08-30
ES2523822T3 (es) 2014-12-01
EP1988085B1 (en) 2014-11-12
EP1988085B8 (en) 2015-01-28
JPWO2007097279A1 (ja) 2009-07-16
KR101374592B1 (ko) 2014-03-17

Similar Documents

Publication Publication Date Title
ZA200709715B (en) Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenylamino]methyl}-1-methyl-1H-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate
ZA200802636B (en) Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as inhibitors of the beta-secretase (BACE)
IL206470A (en) 2-Amino-1 - ((Phosphonooxy) Methyl) -3 - (3 - ((4 - ((2-Pyridinyloxy) Methyl) Phenyl) Methyl) -5-Isoxazolyl) - Pyridinium and Pharmaceutical Preparation Containing It
AU2008229327A8 (en) Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5- phenylimidazolone compounds as beta-secretase inhibitors
SI2097381T1 (sl) 4-(4-((4-kloro-3-(trifluorometil)fenil))karbamoil)amino)-3- fluorofenoksi)-n-metilpiridin-2-karbokasamid monohidrat
CL2008003599A1 (es) Un compuesto 3-[metoxi(fenil)metilen]-2-oxoindolino-6-carboxilato de metilo; y su procedimiento de fabricacion.
IL195417A0 (en) Oral composition comprising 3-[5-[4-(cyclopenthyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl) methoxy]phenyl]propionic acid or salt thereof
IL194952A0 (en) Dvc delta commands
WO2008058118A3 (en) Preparation of montelukast and its salts
PT2167085E (pt) Novas utilizações terapêuticas de 4-[2-(4- metilfenilsulfanil)fenil]piperidina
ZA200807190B (en) Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process
IL178056A0 (en) Oxadiazolone derivatives as ppar delta agonists
PL1988085T3 (pl) Sposób wytwarzania estru, 3-[5-[4-(cyklopentyloksy)-2-hydroksybenzoilo]-2-[(3-hydroksy-1,2-benzisoksazol-6-ilo)metoksy]fenylo]propionianu oraz związek pośredni dla tego sposobu
EE200900024A (et) Meetod 3-(2,2,2-trimetlhdrasiinium)propionaadi dihdraadi valmistamiseks
ZA200809565B (en) 4-(2, e-dichloro-benzoylamino)-1H-pyrazole-s-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the treatment of cancer
WO2007063556A3 (en) An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs
WO2009069643A1 (ja) ３－｛５－［４－（シクロペンチルオキシ）－２－ヒドロキシベンゾイル］－２－［（３－ヒドロキシ－１，２－ベンズイソオキサゾール－６－イル）メトキシ］フェニル｝プロピオン酸またはその塩を含有する固体分散体またはその組成物
HU0600347D0 (en) Process for the preparation of {2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indol-2-one (ziprasidon)
HU0600834D0 (en) Process for the preparation of 2-[2-(1-piperazinyl)-ethoxy]
PL380178A1 (pl) Sposób wytwarzania chlorowodorku 2-[(2, 3, 4-trihydroksyfenylo) metylo] hydrazydu D, L-seryny
FI7140U1 (fi) Järjestely tulisijan valmistamiseksi, muotti ja tulisija
IL209154A0 (en) Process for controlling the particle size of a 3-(trifluoromethyl)phenyl]-1-aminopropane derivative
HK1138843A (en) AMINO-5-[SUBSTITUTED-4-(DIFLUOROMETHOXY)PHENYL]-5- PHENYLIMIDAZOLONE COMPOUNDS AS ß-SECRETASE INHIBITORS
FI20061100A0 (fi) Menetelmä tiilien muuraamiseksi sekä laitteet sen toteuttamiseksi
AU2006902292A0 (en) Method for the production of chelation agent